Global Gabapentin Market Size To Worth USD 3.54 Billion By 2033 | CAGR of 5.16%
Category: HealthcareGlobal Gabapentin Market Size To Worth USD 3.54 Billion By 2033
According to a research report published by Spherical Insights & Consulting, the Global Gabapentin Market Size is Expected to Grow from USD 2.14 Billion in 2023 to USD 3.54 Billion by 2033, at a CAGR of 5.16% during the forecast period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 245 pages with 102 Market data tables and figures & charts from the report on the "Global Gabapentin Market Size, Share, and COVID-19 Impact Analysis, By Type (Generic and Branded), By Dosage Form (Tablet, Capsule, and Oral Solution), By Application (Epilepsy, Neuropathic Pain, Restless Legs Syndrome, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/gabapentin-market
A drug called gabapentin was first created to treat epilepsy. It is also used to treat hot flashes, restless legs syndrome, and neuropathic pain. It functions by altering specific brain chemicals that are involved in the transmission of seizures and pain signals. Gabapentin can be taken with or without meals, and it is often administered orally as tablets or capsules. Neuropathic pain, which results from injury or malfunction of the neurological system, is the main condition that gabapentin is used to treat. Neuropathic pain is becoming more common as a result of aging populations, an increase in chronic illnesses, and increased knowledge of the problem. Rising neuropathic illnesses, growing drug variety in treating off-label medications, ongoing opioid crises, supportive government policies, technological improvements, and continuous research and development (R&D) efforts are some of the reasons driving the gabapentin market. Improvements in pharmaceutical research are one of the main factors driving the market. An additional element contributing to growth is the global rise in the aging population. However, the growing concern about gabapentin's potential for abuse and dependency is a major restriction to the growth of the gabapentin market.
The generic segment is predicted to hold the largest market share through the forecast period.
Based on the type, the gabapentin market is classified into generic and branded. Among these, the generic segment is predicted to hold the largest market share through the forecast period. Generic drugs are more affordable than branded ones, making them available to a larger range of patients.
The capsule segment is anticipated to hold the highest market share during the projected timeframe.
Based on the dosage form, the gabapentin market is divided into tablet, capsule, and oral solution. Among these, the capsule segment is anticipated to hold the highest market share during the projected timeframe. Capsules are praised for being simple to administer, which makes them perfect for patients of all ages.
The epilepsy segment is anticipated to hold the largest market share during the projected timeframe.
Based on the application, the gabapentin market is divided into epilepsy, neuropathic pain, restless legs syndrome, and others. Among these, the epilepsy segment is anticipated to hold the largest market share during the projected timeframe. The reason for this is that it has been shown to be an effective anticonvulsant that is necessary for managing seizures in people with epilepsy.
North America is estimated to hold the largest share of the gabapentin market over the forecast period.
Get more details on this report -
North America is estimated to hold the largest share of the gabapentin market over the forecast period. Numerous medical research and drug development initiatives are supported by the highly developed healthcare system in North America. A favorable market is also being provided by consumers' increased knowledge of healthcare and medicine options as a result of the focus on health.
Asia Pacific is predicted to grow at the highest CAGR growth in the gabapentin market over the forecast period. The market for gabapentin is anticipated to develop significantly in the Asia-Pacific region due to reasons like rising healthcare costs, increased awareness of neuropathic pain, and rising off-label drug use.
Major key players in the gabapentin market include GLENMARK PHARMACEUTICALS LTD., Arbor Pharmaceuticals, LLC., Sun Pharmaceutical Industries Ltd., Ascend Laboratories LLC, B.P. Pharma, Zydus Lifesciences, Teva Pharmaceutical Industries Ltd, Amneal Pharmaceuticals LLC., Cipla, Apotex Inc., Assertio Holdings, Inc., Aurobindo Pharma, Pfizer Inc., and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In January 2024, in order to treat postherpetic neuralgia, Zydus Lifesciences was approval by the USFDA to produce and sell 300 mg and 600 mg once-daily gabapentin tablets. The company plans to introduce these tablets right away.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the gabapentin market based on the below-mentioned segments:
Global Gabapentin Market, By Type
- Generic
- Branded
Global Gabapentin Market, By Dosage Form
- Tablet
- Capsule
- Oral Solution
Global Gabapentin Market, By Application
- Epilepsy
- Neuropathic Pain
- Restless Legs Syndrome
- Others
Global Gabapentin Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?